Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors.

DeVette CI, Andreatta M, Bardet W, Cate SJ, Jurtz VI, Jackson KW, Welm AL, Nielsen M, Hildebrand WH.

Cancer Immunol Res. 2018 Jun;6(6):636-644. doi: 10.1158/2326-6066.CIR-17-0298. Epub 2018 Apr 3.

PMID:
29615400
2.

T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.

McMurtrey C, Harriff MJ, Swarbrick GM, Duncan A, Cansler M, Null M, Bardet W, Jackson KW, Lewinsohn DA, Hildebrand W, Lewinsohn DM.

PLoS One. 2017 Nov 27;12(11):e0188288. doi: 10.1371/journal.pone.0188288. eCollection 2017.

3.

The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands.

Hilton HG, McMurtrey CP, Han AS, Djaoud Z, Guethlein LA, Blokhuis JH, Pugh JL, Goyos A, Horowitz A, Buchli R, Jackson KW, Bardet W, Bushnell DA, Robinson PJ, Mendoza JL, Birnbaum ME, Nielsen M, Garcia KC, Hildebrand WH, Parham P.

Cell Rep. 2017 May 16;19(7):1394-1405. doi: 10.1016/j.celrep.2017.04.059.

4.

Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.

Kaabinejadian S, McMurtrey CP, Kim S, Jain R, Bardet W, Schafer FB, Davenport JL, Martin AD, Diamond MS, Weidanz JA, Hansen TH, Hildebrand WH.

J Immunol. 2016 May 15;196(10):4263-73. doi: 10.4049/jimmunol.1501821. Epub 2016 Apr 20.

5.

Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove.

McMurtrey C, Trolle T, Sansom T, Remesh SG, Kaever T, Bardet W, Jackson K, McLeod R, Sette A, Nielsen M, Zajonc DM, Blader IJ, Peters B, Hildebrand W.

Elife. 2016 Jan 29;5. pii: e12556. doi: 10.7554/eLife.12556.

6.

The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.

Trolle T, McMurtrey CP, Sidney J, Bardet W, Osborn SC, Kaever T, Sette A, Hildebrand WH, Nielsen M, Peters B.

J Immunol. 2016 Feb 15;196(4):1480-7. doi: 10.4049/jimmunol.1501721. Epub 2016 Jan 18.

7.

Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.

Patterson AM, Kaabinejadian S, McMurtrey CP, Bardet W, Jackson KW, Zuna RE, Husain S, Adams GP, MacDonald G, Dillon RL, Ames H, Buchli R, Hawkins OE, Weidanz JA, Hildebrand WH.

Mol Cancer Ther. 2016 Feb;15(2):313-22. doi: 10.1158/1535-7163.MCT-15-0658. Epub 2015 Dec 30.

8.

Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.

Yaciuk JC, Skaley M, Bardet W, Schafer F, Mojsilovic D, Cate S, Stewart CJ, McMurtrey C, Jackson KW, Buchli R, Olvera A, Cedeño S, Plana M, Mothe B, Brander C, West JT, Hildebrand WH.

J Virol. 2014 Nov;88(22):12992-3004. doi: 10.1128/JVI.01914-14. Epub 2014 Aug 27.

9.

Profiling antibodies to class II HLA in transplant patient sera.

McMurtrey C, Lowe D, Buchli R, Daga S, Royer D, Humphrey A, Cate S, Osborn S, Mojsilovic A, VanGundy R, Bardet W, Duty A, Mojsilovic D, Jackson K, Stastny P, Briggs D, Zehnder D, Higgins R, Hildebrand W.

Hum Immunol. 2014 Mar;75(3):261-70. doi: 10.1016/j.humimm.2013.11.015. Epub 2013 Nov 20.

PMID:
24269696
10.

Identification of class I HLA T cell control epitopes for West Nile virus.

Kaabinejadian S, Piazza PA, McMurtrey CP, Vernon SR, Cate SJ, Bardet W, Schafer FB, Jackson KW, Campbell DM, Buchli R, Rinaldo CR, Hildebrand WH.

PLoS One. 2013 Jun 10;8(6):e66298. doi: 10.1371/journal.pone.0066298. Print 2013.

11.

The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection.

Reed JS, Sidney J, Piaskowski SM, Glidden CE, León EJ, Burwitz BJ, Kolar HL, Eernisse CM, Furlott JR, Maness NJ, Walsh AD, Rudersdorf RA, Bardet W, McMurtrey CP, O'Connor DH, Hildebrand WH, Sette A, Watkins DI, Wilson NA.

Immunogenetics. 2011 Dec;63(12):789-807. doi: 10.1007/s00251-011-0541-9. Epub 2011 Jul 6.

12.

HLA class I molecules reflect an altered host proteome after influenza virus infection.

Wahl A, Schafer F, Bardet W, Hildebrand WH.

Hum Immunol. 2010 Jan;71(1):14-22. doi: 10.1016/j.humimm.2009.08.012.

13.

T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.

Wahl A, McCoy W, Schafer F, Bardet W, Buchli R, Fremont DH, Hildebrand WH.

J Virol. 2009 Sep;83(18):9206-14. doi: 10.1128/JVI.00932-09. Epub 2009 Jun 24.

14.

Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.

Loffredo JT, Sidney J, Bean AT, Beal DR, Bardet W, Wahl A, Hawkins OE, Piaskowski S, Wilson NA, Hildebrand WH, Watkins DI, Sette A.

J Immunol. 2009 Jun 15;182(12):7763-75. doi: 10.4049/jimmunol.0900111.

15.

Determination of cellular lipids bound to human CD1d molecules.

Cox D, Fox L, Tian R, Bardet W, Skaley M, Mojsilovic D, Gumperz J, Hildebrand W.

PLoS One. 2009;4(5):e5325. doi: 10.1371/journal.pone.0005325. Epub 2009 May 5.

16.

Mauritian cynomolgus macaques share two exceptionally common major histocompatibility complex class I alleles that restrict simian immunodeficiency virus-specific CD8+ T cells.

Burwitz BJ, Pendley CJ, Greene JM, Detmer AM, Lhost JJ, Karl JA, Piaskowski SM, Rudersdorf RA, Wallace LT, Bimber BN, Loffredo JT, Cox DG, Bardet W, Hildebrand W, Wiseman RW, O'Connor SL, O'Connor DH.

J Virol. 2009 Jun;83(12):6011-9. doi: 10.1128/JVI.00199-09. Epub 2009 Apr 1.

17.

HLA class I molecules consistently present internal influenza epitopes.

Wahl A, Schafer F, Bardet W, Buchli R, Air GM, Hildebrand WH.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):540-5. doi: 10.1073/pnas.0811271106. Epub 2009 Jan 2.

18.

Identification of breast cancer peptide epitopes presented by HLA-A*0201.

Hawkins OE, Vangundy RS, Eckerd AM, Bardet W, Buchli R, Weidanz JA, Hildebrand WH.

J Proteome Res. 2008 Apr;7(4):1445-57. doi: 10.1021/pr700761w. Epub 2008 Mar 18.

PMID:
18345606
19.

Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes.

McMurtrey CP, Lelic A, Piazza P, Chakrabarti AK, Yablonsky EJ, Wahl A, Bardet W, Eckerd A, Cook RL, Hess R, Buchli R, Loeb M, Rinaldo CR, Bramson J, Hildebrand WH.

Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2981-6. doi: 10.1073/pnas.0711874105. Epub 2008 Feb 25.

20.

The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239.

Loffredo JT, Sidney J, Piaskowski S, Szymanski A, Furlott J, Rudersdorf R, Reed J, Peters B, Hickman-Miller HD, Bardet W, Rehrauer WM, O'Connor DH, Wilson NA, Hildebrand WH, Sette A, Watkins DI.

J Immunol. 2005 Nov 1;175(9):5986-97.

21.

Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery.

Buchli R, VanGundy RS, Hickman-Miller HD, Giberson CF, Bardet W, Hildebrand WH.

Biochemistry. 2005 Sep 20;44(37):12491-507.

PMID:
16156661
22.

Rhesus macaque MHC class I molecules present HLA-B-like peptides.

Hickman-Miller HD, Bardet W, Gilb A, Luis AD, Jackson KW, Watkins DI, Hildebrand WH.

J Immunol. 2005 Jul 1;175(1):367-75.

23.

Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization.

Buchli R, VanGundy RS, Hickman-Miller HD, Giberson CF, Bardet W, Hildebrand WH.

Biochemistry. 2004 Nov 23;43(46):14852-63.

PMID:
15544356
24.

Cutting edge: class I presentation of host peptides following HIV infection.

Hickman HD, Luis AD, Bardet W, Buchli R, Battson CL, Shearer MH, Jackson KW, Kennedy RC, Hildebrand WH.

J Immunol. 2003 Jul 1;171(1):22-6.

Supplemental Content

Loading ...
Support Center